HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhongping Cheng Selected Research

Immunotherapy

1/2022Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhongping Cheng Research Topics

Disease

17Neoplasms (Cancer)
10/2022 - 07/2010
16Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 07/2010
9Leiomyoma (Uterine Fibroids)
01/2015 - 02/2011
8Adenomyosis
10/2021 - 03/2009
6Myoma
04/2022 - 05/2008
5Neoplasm Metastasis (Metastasis)
10/2022 - 06/2010
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 10/2020
3Dysmenorrhea (Menstrual Pain)
10/2021 - 03/2009
3Ovarian Epithelial Carcinoma
09/2018 - 06/2010
2Ascites
10/2022 - 07/2010
2Ischemia
08/2022 - 03/2014
2Hemorrhage
10/2021 - 08/2009
2Hypoxia (Hypoxemia)
05/2014 - 03/2014
1Infarction (Infarctions)
08/2022
1Reperfusion Injury
08/2022
1Intraoperative Complications
01/2022
1Microsatellite Instability
01/2022
1Pain (Aches)
10/2021
1Shock
10/2021
1Fibrosis (Cirrhosis)
01/2021
1Postoperative Pain
07/2020
1Pre-Eclampsia (Preeclampsia)
01/2020
1Choriocarcinoma
01/2020
1Infertility (Sterility)
12/2019
1Amenorrhea
12/2019
1Menorrhagia
12/2018
1Ovarian Cysts (Ovarian Cyst)
09/2018
1Carcinogenesis
09/2015

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2008
10Messenger RNA (mRNA)IBA
01/2022 - 06/2013
6Biomarkers (Surrogate Marker)IBA
10/2022 - 04/2019
4RNA (Ribonucleic Acid)IBA
10/2022 - 06/2015
4Biological ProductsIBA
01/2021 - 06/2015
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2019
3Interleukin-8 (Interleukin 8)IBA
01/2020 - 01/2017
3BerberineIBA
07/2019 - 12/2017
2MicroRNAs (MicroRNA)IBA
10/2022 - 04/2022
2AntigensIBA
02/2021 - 04/2019
2Long Noncoding RNAIBA
01/2021 - 09/2015
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019 - 06/2013
2Therapeutic UsesIBA
05/2018 - 05/2014
2LipopolysaccharidesIBA
12/2017 - 01/2015
2matrigelIBA
05/2011 - 07/2010
1Circular RNAIBA
10/2022
1kaempferolIBA
08/2022
1KinesinsIBA
02/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1MethyltransferasesIBA
01/2022
1Hemoglobins (Hemoglobin)IBA
10/2021
1CA-125 Antigen (CA 125 Antigen)IBA
02/2021
1sinomenineIBA
01/2021
1Propofol (Diprivan)FDA LinkGeneric
07/2020
1Tetracaine (Amethocaine)FDA LinkGeneric
07/2020
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020
1FlavonoidsIBA
08/2019
1wogoninIBA
08/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2019
1AutoantibodiesIBA
04/2019
1Macrophage Migration-Inhibitory FactorsIBA
04/2019
1OsteopontinIBA
04/2019
1Complement System Proteins (Complement)IBA
04/2019
1InterleukinsIBA
01/2019
1rho GTPase-activating proteinIBA
12/2018
1Protein Kinases (Protein Kinase)IBA
12/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2018
1HMGB1 Protein (HMG1)IBA
09/2018
1NF-kappa B (NF-kB)IBA
01/2018
1Toll-Like Receptor 4IBA
12/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
10/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2016
1Metalloproteases (Metalloproteinases)IBA
10/2016
1Proto-Oncogene Proteins c-etsIBA
01/2016
1BromidesIBA
09/2014
1Myosin Light Chains (Myosin Essential Light Chain)IBA
09/2014
1Myosins (Myosin)IBA
09/2014
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
09/2014
1Myosin-Light-Chain KinaseIBA
09/2014
1Oxygen (Dioxygen)IBA
05/2014
1Apoptosis Regulatory ProteinsIBA
05/2014
1Heparin (Liquaemin)FDA LinkGeneric
03/2014
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
03/2014
1Inositol (Myoinositol)IBA
03/2014
1Estrogen ReceptorsIBA
03/2014
1Cytochromes c (Cytochrome c)IBA
03/2014

Therapy/Procedure

9Therapeutics
01/2022 - 05/2014
6Hysterectomy
10/2021 - 03/2009
4Uterine Myomectomy
04/2022 - 05/2008
3Drug Therapy (Chemotherapy)
01/2022 - 07/2019
2Length of Stay
01/2022 - 04/2021
2Laparotomy
01/2022 - 04/2021
2Nerve Block (Nerve Blocks)
10/2021 - 10/2019
2Minimally Invasive Surgical Procedures
04/2021 - 01/2018
1Immunotherapy
01/2022
1Catheters
10/2021
1Uterine Artery Embolization
10/2021
1Electrocoagulation (Electrocautery)
10/2021
1Anesthesia
07/2020